Cargando…

Modelling infectious diseases with relapse: a case study of HSV-2

BACKGROUND: Herpes Simplex Virus Type 2 (HSV-2) is one of the most common sexually transmitted diseases. Although there is still no licensed vaccine for HSV-2, a theoretical investigation of the potential effects of a vaccine is considered important and has recently been conducted by several researc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jinliang, Yu, Xiaoqing, Tessmer, Heidi L., Kuniya, Toshikazu, Omori, Ryosuke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512781/ https://www.ncbi.nlm.nih.gov/pubmed/28716140 http://dx.doi.org/10.1186/s12976-017-0059-4

Ejemplares similares

Can Machines Learn Respiratory Virus Epidemiology?: A Comparative Study of Likelihood-Free Methods for the Estimation of Epidemiological Dynamics
por: Tessmer, Heidi L., et al.
Publicado: (2018)

The determinant of periodicity in Mycoplasma pneumoniae incidence: an insight from mathematical modelling
por: Omori, Ryosuke, et al.
Publicado: (2015)

Tracking the Evolution of Polymerase Genes of Influenza A Viruses during Interspecies Transmission between Avian and Swine Hosts
por: Karnbunchob, Nipawit, et al.
Publicado: (2016)

High transmissibility of norovirus among infants and school children during the 2016/17 season in Osaka, Japan
por: Sakon, Naomi, et al.
Publicado: (2018)

Estimating the Lineage Dynamics of Human Influenza B Viruses
por: Nyirenda, Mayumbo, et al.
Publicado: (2016)

Structure of epidemic models: toward further applications in economics
por: Kuniya, Toshikazu
Publicado: (2021)

Prediction of the Epidemic Peak of Coronavirus Disease in Japan, 2020
por: Kuniya, Toshikazu
Publicado: (2020)

Theoretical basis to measure the impact of short-lasting control of an infectious disease on the epidemic peak
por: Omori, Ryosuke, et al.
Publicado: (2011)

Modeling population‐wide testing of SARS‐CoV‐2 for containing COVID‐19 pandemic in Okinawa, Japan
por: Shimizu, Kazuki, et al.
Publicado: (2021)

Worldwide circulation of HSV-2 × HSV-1 recombinant strains
por: Koelle, David M., et al.
Publicado: (2017)

Prediction of COVID‐19 cases during Tokyo's Olympic and Paralympic Games
por: Tokuda, Yasuharu, et al.
Publicado: (2021)

Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women
por: Gilbert, Peter B., et al.
Publicado: (2017)

Modelling diseases with relapse and nonlinear incidence of infection: a multi-group epidemic model
por: Wang, Jinliang, et al.
Publicado: (2014)

Evaluation of the effect of the state of emergency for the first wave of COVID-19 in Japan
por: Kuniya, Toshikazu
Publicado: (2020)

Negative epidemiological association between HSV-1 and HSV-2 infections
por: Nasrallah, Gheyath K., et al.
Publicado: (2019)

A Replication-Defective Herpes Simplex Virus (HSV)-2 Vaccine, HSV529, is Safe and Well-Tolerated in Adults with or without HSV Infection and Induces Significant HSV-2-Specific Antibody Responses in HSV Seronegative Individuals
por: Dropulic, Lesia, et al.
Publicado: (2017)

Evaluation of infectious titer in a candidate HSV type 2 vaccine by a quantitative molecular approach
por: Azizi, Ali, et al.
Publicado: (2013)

Reconsideration of r/K Selection Theory Using Stochastic Control Theory and Nonlinear Structured Population Models
por: Oizumi, Ryo, et al.
Publicado: (2016)

Parameter estimation and prediction for coronavirus disease outbreak 2019 (COVID-19) in Algeria
por: Bentout, Soufiane, et al.
Publicado: (2020)

Potential impact of alternative vaccination strategies on COVID‐19 cases, hospitalization, and mortality in Japan during 2021–2022
por: Tokuda, Yasuharu, et al.
Publicado: (2021)

A Macaque Model to Study Vaginal HSV-2/Immunodeficiency Virus Co-Infection and the Impact of HSV-2 on Microbicide Efficacy
por: Crostarosa, Federica, et al.
Publicado: (2009)

HSV-2- and HIV-1- permissive cell lines co-infected by HSV-2 and HIV-1 co-replicate HSV-2 and HIV-1 without production of HSV-2/HIV-1 pseudotype particles
por: LeGoff, Jérôme, et al.
Publicado: (2007)

SOCS4 expressed by recombinant HSV protects against cytokine storm in a mouse model
por: Ren, Shuqi, et al.
Publicado: (2019)

A case of an atypical resistant granulomatous HSV-1 and HSV-2 ulceration in an AIDS patient treated with intralesional cidofovir
por: Saling, Christopher, et al.
Publicado: (2019)

Expression of HSV-1 Receptors in EBV-Associated Lymphoproliferative Disease Determines Susceptibility to Oncolytic HSV
por: Wang, Pin-Yi, et al.
Publicado: (2012)

Application of the backstepping method to the prediction of increase or decrease of infected population
por: Kuniya, Toshikazu, et al.
Publicado: (2016)

Possible effects of mixed prevention strategy for COVID-19 epidemic: massive testing, quarantine and social distancing
por: Kuniya, Toshikazu, et al.
Publicado: (2020)

Review of mathematical models of HSV-2 vaccination: Implications for vaccine development
por: Spicknall, Ian H., et al.
Publicado: (2019)

Molecular docking analysis of a secondary metabolite with the glycoprotein receptors of HSV 1 and HSV 2
por: Saran, Natarajan, et al.
Publicado: (2019)

The R2 non-neuroinvasive HSV-1 vaccine affords protection from genital HSV-2 infections in a guinea pig model
por: Bernstein, David I., et al.
Publicado: (2020)

Comparative Evaluation of AmpliVue HSV 1+2 Assay with ELVIS Culture for Detecting Herpes Simplex Virus 1 (HSV-1) and HSV-2 in Clinical Specimens
por: Granato, Paul A., et al.
Publicado: (2015)

The population impact of herpes simplex virus type 2 (HSV-2) vaccination on the incidence of HSV-2, HIV and genital ulcer disease in South Africa: a mathematical modelling study
por: Stone, Jack, et al.
Publicado: (2023)

An Adenovirus-Based Recombinant Herpes Simplex Virus 2 (HSV-2) Therapeutic Vaccine Is Highly Protective against Acute and Recurrent HSV-2 Disease in a Guinea Pig Model
por: Wan, Mingming, et al.
Publicado: (2023)

Elsberg syndrome in HSV-2 infection
por: Belfaqeeh, Omar, et al.
Publicado: (2023)

Model of vaccine efficacy against HSV-2 superinfection of HSV-1 seropositive mice demonstrates protection by antibodies mediating cellular cytotoxicity
por: Burn Aschner, Clare, et al.
Publicado: (2020)

A Systematic Review of Second-Line Treatments in Antiviral Resistant Strains of HSV-1, HSV-2, and VZV
por: Lince, Kimberly C, et al.
Publicado: (2023)

Production of high titre disabled infectious single cycle (DISC) HSV from a microcarrier culture
por: Zecchini, T.A., et al.
Publicado: (1999)

Stress Hormones Epinephrine and Corticosterone Selectively Reactivate HSV-1 and HSV-2 in Sympathetic and Sensory Neurons
por: Goswami, Poorna, et al.
Publicado: (2022)

Psoromic Acid, a Lichen-Derived Molecule, Inhibits the Replication of HSV-1 and HSV-2, and Inactivates HSV-1 DNA Polymerase: Shedding Light on Antiherpetic Properties
por: Hassan, Sherif T. S., et al.
Publicado: (2019)

Risk Factors for HSV-2 Infection among Sexual Partners of HSV-2/HIV-1 Co-Infected Persons
por: Mujugira, Andrew, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_isp30s09h12208lfm57it07o5e